{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:18Z","timestamp":1740149838070,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12288-021-01483-0","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T19:02:28Z","timestamp":1630004548000},"page":"492-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gastric MALT Lymphoma: A 8-Year Experience"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-0325","authenticated-orcid":false,"given":"Maria Eduarda","family":"Couto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Viterbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngelo","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il\u00eddia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Esp\u00edrito Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio","family":"Chacim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulcineia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"1483_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcancer.2016.07.003","volume":"39","author":"MQ Du","year":"2016","unstructured":"Du MQ (2016) MALT lymphoma: a paradigm of NF-kB dysregulation. Semin Cancer Biol 39:49\u201360","journal-title":"Semin Cancer Biol"},{"issue":"8776","key":"1483_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR et al (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338(8776):1175\u20131176","journal-title":"Lancet"},{"doi-asserted-by":"crossref","unstructured":"Nakamura S, Yao T, Aoyagi K, et al. 1997 Helicobacter pylori and primary gastric lymphoma A histopathologic and immunohistochemical analysis of 237 patients. Cancer. 79(1): 3\u201311","key":"1483_CR3","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P"},{"issue":"12","key":"1483_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJM199803193381205","volume":"338","author":"E Zucca","year":"1998","unstructured":"Zucca E, Bertoni F, Roggero E et al (1998) Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosaassociated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338(12):804\u2013810","journal-title":"N Engl J Med"},{"issue":"2","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F et al (2010) Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8(2):105\u2013110","journal-title":"Clin Gastroenterol Hepatol"},{"doi-asserted-by":"crossref","unstructured":"Luminari S, Cesaretti M, Marcheselli L, et al. 2010 Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol. 21(4): 855\u2013859","key":"1483_CR6","DOI":"10.1093\/annonc\/mdp402"},{"issue":"26","key":"1483_CR7","doi-asserted-by":"publisher","first-page":"8014","DOI":"10.3748\/wjg.v21.i26.8014","volume":"21","author":"N Asano","year":"2015","unstructured":"Asano N, Iijima K, Koike T et al (2015) Helicobacter pylori -negative gastric mucosa-associated lymphoid tissue lymphomas: A review. World J Gastroenterol 21(26):8014\u20138020","journal-title":"World J Gastroenterol"},{"unstructured":"NCCN Clinical Practice Guidelines in Oncology. B-cell Lymphomas. Version 1.2020. January 22, 2020","key":"1483_CR8"},{"doi-asserted-by":"crossref","unstructured":"Zucca E, Arcaini L, Buske C, et al, 2020 on behalf of the ESMO Guidelines Committee. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 31(1): 17\u201329","key":"1483_CR9","DOI":"10.1016\/j.annonc.2019.10.010"},{"issue":"16","key":"1483_CR10","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","volume":"44","author":"LG Capelle","year":"2008","unstructured":"Capelle LG, de Vries AC, Looman CW et al (2008) Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 44(16):2470\u20132476","journal-title":"Eur J Cancer"},{"issue":"4","key":"1483_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.gastro.2012.06.035","volume":"143","author":"T Wundisch","year":"2012","unstructured":"Wundisch T, Dieckhoff P, Greene B et al (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 143(4):936\u2013942","journal-title":"Gastroenterology"},{"issue":"10","key":"1483_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/jjco\/hyi164","volume":"35","author":"SY Lee","year":"2005","unstructured":"Lee SY, Kim JJ, Lee JH et al (2005) Synchronous adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma in a single stomach. Jpn J Clin Oncol 35(10):591\u2013594","journal-title":"Jpn J Clin Oncol"},{"unstructured":"Cammarota G, Larocca LM, D\u2019Ugo D et al. 2001 Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? Hepatogastroenterology 48:104\u20136","key":"1483_CR13"},{"unstructured":"Swerdlow SH, Campo E. Harris NL et al. 2017 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Revised 4th Edition. IARC Press: Lyon","key":"1483_CR14"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, d\u2019Amore F, Coiffer B et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5:397\u2013400","journal-title":"Ann Oncol"},{"key":"1483_CR16","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","volume":"52","author":"C Copie-Bergman","year":"2003","unstructured":"Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Fl\u00e9jou JF, Dordonne K, de Mascarel A, Wotherspoon AC (2003) Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 52:1656","journal-title":"Gut"},{"doi-asserted-by":"crossref","unstructured":"Gisbert JP, Aguado B, Luna M, et al. 2006 Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Rev Esp Enferm Dig. 98: 655\u2013665.","key":"1483_CR17","DOI":"10.4321\/S1130-01082006000900003"},{"key":"1483_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E (1997) Clinical Features, Treatment and Outcome in a Series of 93 Patients with Low-Grade Gastric MALT Lymphoma. Leuk Lymphoma 26:527\u2013537","journal-title":"Leuk Lymphoma"},{"key":"1483_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. NEJM 329:987\u2013994","journal-title":"NEJM"},{"issue":"12","key":"1483_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","volume":"130","author":"C Thieblemont","year":"2017","unstructured":"Thieblemont C, Cascione L, Conconi A et al (2017) A MALT lymphoma prognostic index. Blood 130(12):1409\u20131417","journal-title":"Blood"},{"issue":"5","key":"1483_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ajh.25446","volume":"94","author":"JP Alderuccio","year":"2019","unstructured":"Alderuccio JP, Zhao W, Desai A et al (2019) Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation. Am J Hematol 94(5):585\u2013596","journal-title":"Am J Hematol"},{"issue":"98","key":"1483_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00277-018-3516-1","volume":"2019","author":"J Hong","year":"2019","unstructured":"Hong J, Cho J, Hye Ko Y et al (2019) Validation of the Marginal Zone Lymphoma International Prognostic Index. Ann Hematol 2019(98):457\u2013464","journal-title":"Ann Hematol"},{"key":"1483_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ajh.25473","volume":"94","author":"SI Tracy","year":"2019","unstructured":"Tracy SI, Larson MC, Feldman AL et al (2019) The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas. Am J Hematol 94:658","journal-title":"Am J Hematol"},{"doi-asserted-by":"crossref","unstructured":"Salar A, Domingo-Domenech E, Panizo C. et al. 2017\u00a0Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood. 130 (15): 1772\u20131774","key":"1483_CR24","DOI":"10.1182\/blood-2017-07-795302"},{"doi-asserted-by":"crossref","unstructured":"Teixeira-Mendes\u00a0LS,\u00a0Attygalle\u00a0A, Wotherspoon\u00a0A. 2014 Helicobacter pylori\u00a0infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation. Gut. 63:1526\u20131527","key":"1483_CR25","DOI":"10.1136\/gutjnl-2014-307389"},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00277-014-2298-3","volume":"94","author":"M Raderer","year":"2015","unstructured":"Raderer M, Wohrer S, Kiesewetter B et al (2015) Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up. Ann Hematol 94:969\u2013973","journal-title":"Ann Hematol"},{"issue":"7","key":"1483_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1586\/eri.09.55","volume":"7","author":"A Saleem","year":"2009","unstructured":"Saleem A, Qasim A, O\u2019Connor HJ et al (2009) Pylera for the eradication for helicobacter pylori infection. Expert Rev Anti Infect Ther 7(7):793\u2013799","journal-title":"Expert Rev Anti Infect Ther"},{"doi-asserted-by":"crossref","unstructured":"Chey DW, Leontiadis GI, Howden CW, Moss SF. 2017 ACG Clinical guidelines: treatment of Helicobacter pylori infection. The American Journal of Gastroenterology. 112:212\u2013238","key":"1483_CR28","DOI":"10.1038\/ajg.2016.563"},{"doi-asserted-by":"crossref","unstructured":"Zucca E, Bertoni F. 2016 The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 127(17): 2082\u20132092","key":"1483_CR29","DOI":"10.1182\/blood-2015-12-624304"},{"doi-asserted-by":"crossref","unstructured":"Kiesewetter B, Ferreri AJM, Raderer M. 2015 Chemoimmunotherapy forMucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature. The Oncologist. 20:915\u2013925","key":"1483_CR30","DOI":"10.1634\/theoncologist.2015-0109"},{"key":"1483_CR31","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3892\/ol.2017.6402","volume":"14","author":"X Li","year":"2017","unstructured":"Li X, Meng Q, Sun S et al (2017) Histological transformation from gastric mucosa-associated lymphoid tissue lymphoma to gastric diffuse large B-cell lymphoma. Oncol Lett 14:2244\u20132248","journal-title":"Oncol Lett"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-021-01483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-021-01483-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-021-01483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:43:20Z","timestamp":1655783000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-021-01483-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1007\/s12288-021-01483-0","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"type":"print","value":"0971-4502"},{"type":"electronic","value":"0974-0449"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"28 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}